{"entity":{"type":"insider","cik":"0001690310","url":"/insider/0001690310","json_url":"/insider/0001690310.json","name":"Medicxi Growth I LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":6,"first":"2021-06-04","last":"2026-06-24","span_basis":"filed_date"},"name_variants":[{"name":"Medicxi Growth I LP","source":"filing","n_filings":6,"first_seen":"2021-06-04","last_seen":"2026-06-24"}],"transactions":[{"id":5930500,"accession":"0001193125-26-281115","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001193125-26-281115","line_url":"/filing/0001193125-26-281115#line-6","is_derivative":false,"issuer_cik":"0001690310","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001690310","owner_cik":null,"owner_name":"Medicxi Co-Invest I LP; Medicxi Growth Co-Invest I LP; Medicxi Growth I GP Ltd; Medicxi Growth I LP; Medicxi Secondary Co-Invest I LP; Medicxi Secondary I GP Ltd.; Medicxi Secondary I LP; Medicxi Ventures I GP Ltd; Medicxi Ventures I LP; Medicxi Ventures Management (Jersey) Ltd","owner_display_name":"Medicxi Co-Invest I LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11197303.0,"shares_display":"11,197,303","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-24","filed_date":"2026-06-24","scope":"insider"},{"id":5930498,"accession":"0001193125-26-281115","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001193125-26-281115","line_url":"/filing/0001193125-26-281115#line-5","is_derivative":false,"issuer_cik":"0001690310","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001690310","owner_cik":null,"owner_name":"Medicxi Co-Invest I LP; Medicxi Growth Co-Invest I LP; Medicxi Growth I GP Ltd; Medicxi Growth I LP; Medicxi Secondary Co-Invest I LP; Medicxi Secondary I GP Ltd.; Medicxi Secondary I LP; Medicxi Ventures I GP Ltd; Medicxi Ventures I LP; Medicxi Ventures Management (Jersey) Ltd","owner_display_name":"Medicxi Co-Invest I LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4398519.0,"shares_display":"4,398,519","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-24","filed_date":"2026-06-24","scope":"insider"},{"id":5930497,"accession":"0001193125-26-281115","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-26-281115","line_url":"/filing/0001193125-26-281115#line-4","is_derivative":false,"issuer_cik":"0001690310","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001690310","owner_cik":null,"owner_name":"Medicxi Co-Invest I LP; Medicxi Growth Co-Invest I LP; Medicxi Growth I GP Ltd; Medicxi Growth I LP; Medicxi Secondary Co-Invest I LP; Medicxi Secondary I GP Ltd.; Medicxi Secondary I LP; Medicxi Ventures I GP Ltd; Medicxi Ventures I LP; Medicxi Ventures Management (Jersey) Ltd","owner_display_name":"Medicxi Co-Invest I LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3936970.0,"shares_display":"3,936,970","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-24","filed_date":"2026-06-24","scope":"insider"},{"id":5930495,"accession":"0001193125-26-281115","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-281115","line_url":"/filing/0001193125-26-281115#line-3","is_derivative":false,"issuer_cik":"0001690310","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001690310","owner_cik":null,"owner_name":"Medicxi Co-Invest I LP; Medicxi Growth Co-Invest I LP; Medicxi Growth I GP Ltd; Medicxi Growth I LP; Medicxi Secondary Co-Invest I LP; Medicxi Secondary I GP Ltd.; Medicxi Secondary I LP; Medicxi Ventures I GP Ltd; Medicxi Ventures I LP; Medicxi Ventures Management (Jersey) Ltd","owner_display_name":"Medicxi Co-Invest I LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":281162.0,"shares_display":"281,162","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-24","filed_date":"2026-06-24","scope":"insider"},{"id":5930494,"accession":"0001193125-26-281115","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-281115","line_url":"/filing/0001193125-26-281115#line-2","is_derivative":false,"issuer_cik":"0001690310","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001690310","owner_cik":null,"owner_name":"Medicxi Co-Invest I LP; Medicxi Growth Co-Invest I LP; Medicxi Growth I GP Ltd; Medicxi Growth I LP; Medicxi Secondary Co-Invest I LP; Medicxi Secondary I GP Ltd.; Medicxi Secondary I LP; Medicxi Ventures I GP Ltd; Medicxi Ventures I LP; Medicxi Ventures Management (Jersey) Ltd","owner_display_name":"Medicxi Co-Invest I LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":93526.0,"shares_display":"93,526","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-24","filed_date":"2026-06-24","scope":"insider"},{"id":5930493,"accession":"0001193125-26-281115","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-281115","line_url":"/filing/0001193125-26-281115#line-1","is_derivative":false,"issuer_cik":"0001690310","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001690310","owner_cik":null,"owner_name":"Medicxi Co-Invest I LP; Medicxi Growth Co-Invest I LP; Medicxi Growth I GP Ltd; Medicxi Growth I LP; Medicxi Secondary Co-Invest I LP; Medicxi Secondary I GP Ltd.; Medicxi Secondary I LP; Medicxi Ventures I GP Ltd; Medicxi Ventures I LP; Medicxi Ventures Management (Jersey) Ltd","owner_display_name":"Medicxi Co-Invest I LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55677.0,"shares_display":"55,677","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-24","filed_date":"2026-06-24","scope":"insider"},{"id":5195002,"accession":"0000899243-21-046968","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-046968","line_url":"/filing/0000899243-21-046968","is_derivative":false,"issuer_cik":"0001690310","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001690310","owner_cik":null,"owner_name":"Medicxi Growth Co-Invest I LP; Medicxi Growth I GP Ltd; Medicxi Ventures Management (Jersey) Ltd; Medicxi Growth I LP","owner_display_name":"Medicxi Growth Co-Invest I LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":34326.0,"shares_display":"34,326","price_per_share":12.82,"price_display":"12.82","price_state":"stated","total_value":440059.32,"total_display":"440,059.32","total_whole":"440,059","shares_owned_after":3936970.0,"shares_owned_after_display":"3,936,970","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-02","filed_date":"2021-12-06","scope":"insider","n_lines":2},{"id":4930304,"accession":"0000899243-21-046591","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-046591","line_url":"/filing/0000899243-21-046591","is_derivative":false,"issuer_cik":"0001690310","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001690310","owner_cik":null,"owner_name":"Medicxi Growth I GP Ltd; Medicxi Growth Co-Invest I LP; Medicxi Ventures Management (Jersey) Ltd; Medicxi Growth I LP","owner_display_name":"Medicxi Growth I GP Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":60304.0,"shares_display":"60,304","price_per_share":12.62,"price_display":"12.62","price_state":"stated","total_value":761036.48,"total_display":"761,036.48","total_whole":"761,036","shares_owned_after":3903440.0,"shares_owned_after_display":"3,903,440","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-01","filed_date":"2021-12-02","scope":"insider","n_lines":2},{"id":4930298,"accession":"0000899243-21-046591","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-046591","line_url":"/filing/0000899243-21-046591","is_derivative":false,"issuer_cik":"0001690310","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001690310","owner_cik":null,"owner_name":"Medicxi Growth I GP Ltd; Medicxi Growth Co-Invest I LP; Medicxi Ventures Management (Jersey) Ltd; Medicxi Growth I LP","owner_display_name":"Medicxi Growth I GP Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":36847.0,"shares_display":"36,847","price_per_share":11.62,"price_display":"11.62","price_state":"stated","total_value":428162.14,"total_display":"428,162.14","total_whole":"428,162","shares_owned_after":3844535.0,"shares_owned_after_display":"3,844,535","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-30","filed_date":"2021-12-02","scope":"insider","n_lines":2},{"id":4605567,"accession":"0000899243-21-046316","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-046316","line_url":"/filing/0000899243-21-046316","is_derivative":false,"issuer_cik":"0001690310","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001690310","owner_cik":null,"owner_name":"Medicxi Ventures Management (Jersey) Ltd; Medicxi Growth Co-Invest I LP; Medicxi Growth I LP; Medicxi Growth I GP Ltd","owner_display_name":"Medicxi Ventures Management (Jersey) Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":56706.0,"shares_display":"56,706","price_per_share":11.7003,"price_display":"11.70","price_state":"stated","total_value":663477.2118,"total_display":"663,477.21","total_whole":"663,477","shares_owned_after":3808543.0,"shares_owned_after_display":"3,808,543","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-29","filed_date":"2021-11-30","scope":"insider","n_lines":2},{"id":4605558,"accession":"0000899243-21-046316","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-046316","line_url":"/filing/0000899243-21-046316","is_derivative":false,"issuer_cik":"0001690310","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001690310","owner_cik":null,"owner_name":"Medicxi Ventures Management (Jersey) Ltd; Medicxi Growth Co-Invest I LP; Medicxi Growth I LP; Medicxi Growth I GP Ltd","owner_display_name":"Medicxi Ventures Management (Jersey) Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11817.0,"shares_display":"11,817","price_per_share":11.3353,"price_display":"11.34","price_state":"stated","total_value":133949.2401,"total_display":"133,949.24","total_whole":"133,949","shares_owned_after":3753152.0,"shares_owned_after_display":"3,753,152","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-26","filed_date":"2021-11-30","scope":"insider","n_lines":2},{"id":5364677,"accession":"0000899243-21-043033","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-043033","line_url":"/filing/0000899243-21-043033","is_derivative":false,"issuer_cik":"0001501796","issuer_name":"Aura Biosciences, Inc.","issuer_ticker":"AURA","issuer_name_source":null,"issuer_url":"/issuer/0001501796","owner_cik":null,"owner_name":"Medicxi Growth Co-Invest I LP; Medicxi Ventures Management (Jersey) Ltd; Medicxi Growth I LP; Medicxi Growth I GP Ltd","owner_display_name":"Medicxi Growth Co-Invest I LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":710000.0,"shares_display":"710,000","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":9940000.0,"total_display":"9,940,000.00","total_whole":"9,940,000","shares_owned_after":2969352.0,"shares_owned_after_display":"2,969,352","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-02","filed_date":"2021-11-04","scope":"insider","n_lines":2},{"id":5455291,"accession":"0000899243-21-022048","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-022048","line_url":"/filing/0000899243-21-022048","is_derivative":false,"issuer_cik":"0001690310","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001690310","owner_cik":null,"owner_name":"Medicxi Growth Co-Invest I LP; Medicxi Growth I LP; Medicxi Growth I GP Ltd; Medicxi Ventures Management (Jersey) Ltd","owner_display_name":"Medicxi Growth Co-Invest I LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":600000.0,"shares_display":"600,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":12000000.0,"total_display":"12,000,000.00","total_whole":"12,000,000","shares_owned_after":3741609.0,"shares_owned_after_display":"3,741,609","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-02","filed_date":"2021-06-04","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001847903","name":"Centessa Pharmaceuticals plc","url":"/issuer/0001847903","role":"Ten percent owner","n_filings":5,"first_seen":"2021-06-04","last_seen":"2026-06-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001501796","name":"Aura Biosciences, Inc.","url":"/issuer/0001501796","role":"Ten percent owner","n_filings":1,"first_seen":"2021-11-04","last_seen":"2021-11-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001690310","retrieved_at":"2026-08-22T21:15:58+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}